[HTML][HTML] Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised …
…, P Narakorn, S Surichan, S Prangpratanporn… - …, 2022 - thelancet.com
Background Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low-
and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based …
and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based …
